533 related articles for article (PubMed ID: 32381118)
1. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
Cheng Y; Tian DY; Wang YJ
Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
[TBL] [Abstract][Full Text] [Related]
2. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.
Li Y; Zhang J; Wan J; Liu A; Sun J
Biomed Pharmacother; 2020 Dec; 132():110887. PubMed ID: 33254429
[TBL] [Abstract][Full Text] [Related]
3. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
[TBL] [Abstract][Full Text] [Related]
4. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
Xin SH; Tan L; Cao X; Yu JT; Tan L
Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
[TBL] [Abstract][Full Text] [Related]
5. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease.
Zhang X; O'Callaghan P; Li H; Tan Y; Zhang G; Barash U; Wang X; Lannfelt L; Vlodavsky I; Lindahl U; Li JP
Acta Neuropathol Commun; 2021 May; 9(1):84. PubMed ID: 33971986
[TBL] [Abstract][Full Text] [Related]
6. Electroacupuncture Improves Clearance of Amyloid-
Liang PZ; Li L; Zhang YN; Shen Y; Zhang LL; Zhou J; Wang ZJ; Wang S; Yang S
Neural Plast; 2021; 2021():9960304. PubMed ID: 34484327
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease.
Uddin MS; Kabir MT; Tewari D; Mamun AA; Mathew B; Aleya L; Barreto GE; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
J Neurol Sci; 2020 Sep; 416():116974. PubMed ID: 32559516
[TBL] [Abstract][Full Text] [Related]
8. Connections Between Amyloid Beta and the Meningeal Lymphatics As a Possible Route for Clearance and Therapeutics.
Dupont G; Iwanaga J; Yilmaz E; Tubbs RS
Lymphat Res Biol; 2020 Feb; 18(1):2-6. PubMed ID: 31433264
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Therapeutic Strategies in Alzheimer's Disease: From Brain to Periphery.
Yu JT; Zhang C
Neurotox Res; 2016 Feb; 29(2):197-200. PubMed ID: 26597964
[TBL] [Abstract][Full Text] [Related]
10. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
[TBL] [Abstract][Full Text] [Related]
11. Clearance systems in the brain-implications for Alzheimer disease.
Tarasoff-Conway JM; Carare RO; Osorio RS; Glodzik L; Butler T; Fieremans E; Axel L; Rusinek H; Nicholson C; Zlokovic BV; Frangione B; Blennow K; Ménard J; Zetterberg H; Wisniewski T; de Leon MJ
Nat Rev Neurol; 2015 Aug; 11(8):457-70. PubMed ID: 26195256
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects.
Goodman JR; Adham ZO; Woltjer RL; Lund AW; Iliff JJ
Brain Behav Immun; 2018 Oct; 73():34-40. PubMed ID: 30055243
[TBL] [Abstract][Full Text] [Related]
13. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation.
Goulay R; Mena Romo L; Hol EM; Dijkhuizen RM
Transl Stroke Res; 2020 Aug; 11(4):601-614. PubMed ID: 31776837
[TBL] [Abstract][Full Text] [Related]
14. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
Alvira-Botero X; Carro EM
Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
[TBL] [Abstract][Full Text] [Related]
15. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
Wang YJ; Zhou HD; Zhou XF
Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Chai AB; Leung GKF; Callaghan R; Gelissen IC
FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
18. Interaction between blood-brain barrier and glymphatic system in solute clearance.
Verheggen ICM; Van Boxtel MPJ; Verhey FRJ; Jansen JFA; Backes WH
Neurosci Biobehav Rev; 2018 Jul; 90():26-33. PubMed ID: 29608988
[TBL] [Abstract][Full Text] [Related]
19. L-3-n-Butylphthalide Effectively Improves the Glymphatic Clearance and Reduce Amyloid-β Deposition in Alzheimer's Transgenic Mice.
Zhang B; Li W; Zhuo Y; Xiang H; Li W; Liu H; Xie L; Gao Q; Tan S
J Mol Neurosci; 2021 Jun; 71(6):1266-1274. PubMed ID: 33188502
[TBL] [Abstract][Full Text] [Related]
20. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.
Ullah R; Park TJ; Huang X; Kim MO
Ageing Res Rev; 2021 Nov; 71():101451. PubMed ID: 34450351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
